Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona M Russell

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Vaccines|July 27, 2024
Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate VaccinationFulgence Niyibitegeka, Fiona M Russell, Mark Jit, et al.
Frontiers in Public Health|August 16, 2023
Risk factors for SARS-CoV-2 infection during the early stages of the COVID-19 pandemic: a systematic literature reviewMatthew Harris, John Hart, Oashe Bhattacharya, et al.
The Lancet. Global Health|November 19, 2023
World Society for Pediatric Infectious Diseases calls for action to ensure fair prices for vaccinesFiona M Russell, Asha Bowen, Mark Cotton, et al.
The Journal of Infection|January 8, 2025
Lack of correlation between school reopening and trends in adult COVID-19 hospitalisations and death rates during the Delta and early Omicron periods: An ecological analysis of five countriesDarren Suryawijaya Ong, Matthew Harris, John D Hart, et al.
Journal of Global Health|February 3, 2023
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years oldRita Reyburn, Anthea Tsatsaronis, Claire von Mollendorf, et al.
International Journal of Molecular Sciences|January 11, 2024
BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 PhosphorylationSimon A Hawley, Fiona M Russell, Fiona A Ross, et al.
The Biochemical Journal|November 14, 2023
Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancersFiona A Ross, Simon A Hawley, Fiona M Russell, et al.
Journal of Clinical Microbiology|July 30, 2010
Comparison of citrated human blood, citrated sheep blood, and defibrinated sheep blood Mueller-Hinton agar preparations for antimicrobial susceptibility testing of Streptococcus pneumoniae isolatesCatherine Satzke, Anna Seduadua, Reginald Chandra, et al.
Vaccine|April 9, 2023
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of ageIsatou Jagne, Claire von Mollendorf, Ashleigh Wee-Hee, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2010
Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccineAnne Balloch, Paul V Licciardi, Fiona M Russell, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Vaccines|July 27, 2024
Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate VaccinationFulgence Niyibitegeka, Fiona M Russell, Mark Jit, et al.
Frontiers in Public Health|August 16, 2023
Risk factors for SARS-CoV-2 infection during the early stages of the COVID-19 pandemic: a systematic literature reviewMatthew Harris, John Hart, Oashe Bhattacharya, et al.
The Lancet. Global Health|November 19, 2023
World Society for Pediatric Infectious Diseases calls for action to ensure fair prices for vaccinesFiona M Russell, Asha Bowen, Mark Cotton, et al.
The Journal of Infection|January 8, 2025
Lack of correlation between school reopening and trends in adult COVID-19 hospitalisations and death rates during the Delta and early Omicron periods: An ecological analysis of five countriesDarren Suryawijaya Ong, Matthew Harris, John D Hart, et al.
Journal of Global Health|February 3, 2023
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years oldRita Reyburn, Anthea Tsatsaronis, Claire von Mollendorf, et al.
International Journal of Molecular Sciences|January 11, 2024
BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 PhosphorylationSimon A Hawley, Fiona M Russell, Fiona A Ross, et al.
The Biochemical Journal|November 14, 2023
Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancersFiona A Ross, Simon A Hawley, Fiona M Russell, et al.
Journal of Clinical Microbiology|July 30, 2010
Comparison of citrated human blood, citrated sheep blood, and defibrinated sheep blood Mueller-Hinton agar preparations for antimicrobial susceptibility testing of Streptococcus pneumoniae isolatesCatherine Satzke, Anna Seduadua, Reginald Chandra, et al.
Vaccine|April 9, 2023
A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of ageIsatou Jagne, Claire von Mollendorf, Ashleigh Wee-Hee, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2010
Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccineAnne Balloch, Paul V Licciardi, Fiona M Russell, et al.
Pageof 11